Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hangzhou Anysoft Information Technology
300571
5
Sino-High
301076
US Stock MarketDetailed Quotes
ENGN enGene Holdings
- 3.990
- +0.100+2.57%
Close Apr 28 16:00 ET
- 3.990
- 0.0000.00%
Post 16:05 ET
203.40MMarket Cap-2.95P/E (TTM)
4.080High3.750Low93.82KVolume3.860Open3.890Pre Close367.31KTurnover0.38%Turnover RatioLossP/E (Static)50.98MShares15.74252wk High0.81P/B97.60MFloat Cap3.50052wk Low--Dividend TTM24.46MShs Float47.170Historical High--Div YieldTTM8.48%Amplitude3.500Historical Low3.915Avg Price1Lot Size
About enGene Holdings Company
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Company Profile
SymbolENGN
Company NameenGene Holdings
Listing DateFeb 1, 2022
Founded2023
CEOMr. Ronald H.W. Cooper
MarketNASDAQ
Employees57
Fiscal Year Ends10-31
Address4868 Rue Levy,Suite 220
CitySaint-Laurent
ProvinceQuébec
CountryCanada
Zip CodeH4R 2P1
Phone1-514-332-4888
Websitehttp://www.engene.com
Company Executives
- Name
- Position
- Salary
- Ronald H.W. Cooper
- President, Chief Executive Officer and Director
- --
- Dr. Raj Som Pruthi, M.D.
- Chief Medical Officer
- --
- Joan Connolly
- Chief Technology Officer
- --
- Dr. Anthony Tzeyew Cheung, PhD
- Chief Scientific Officer
- --
- Dr. Alexander Julian Nichols
- Chief Strategy Officer and Chief Operations Officer of Company and EnGene Inc
- 969.95K
- Ryan Daws
- Chief Financial Officer, Head of Business Development and Principal Accounting Officer
- --
- Dr. Richard M. Glickman,L.L.D.
- Independent Director; Chairman of the Board of EnGene Inc
- --
- Lota S. Zoth, C.P.A.
- Director
- --
- Wouter Joustra
- Independent Director
- --
- Paul J. Hastings
- Independent Director
- --
- Gerald Brunk
- Independent Director
- --
- Dr. Jasper Bos, PhD
- Independent Director
- --
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now